Unibest

Pharmaceutical intermediates

Febuxostat Intermediates

2 pharmaceutical intermediates for Febuxostat. Indication: Hyperuricemia; Gout.

提交项目All intermediates

About Febuxostat

Originator
Teijin Limited
Indication
Hyperuricemia; Gout
Approved Date
02/13/2009
DS/DP
09/08/2031

Available intermediates

2 intermediates currently listed for Febuxostat. Request specifications, documentation or a quotation for any item below.

Febuxostat intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
Ethyl 2-(3-Formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate161798-01-2//
Ethyl 2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylate161797-99-5//

Other programs under F

Fexuprazan HClFezolinetantFilgotinib MaleateFinerenoneFluralanerFostamatinib disodium hexahydrateFruquintinibFutibatinib

Building toward Febuxostat?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →